Generation of Glucocorticoid-Resistant SARS-CoV-2 T Cells for Adoptive Cell Therapy

0
22
To assess the mechanisms contributing to protection, investigators analyzed humoral and T cell responses three weeks after a single BNT162b2 dose.
[Cell Host & Microbe]
Basar, R., Uprety, N., Ensley, E., Daher, M., Klein, K., Martinez, F., Aung, F., Shanley, M., Hu, B., Gokdemir, E., Cortes, A. K. N., Mendt, M., Silva, F. R., Acharya, S., Laskowski, T., Muniz-Feliciano, L., Banerjee, P. P., Li, Y., Li, S., … Rezvani, K. (2021). Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2021.109432 Cite
Full ArticleGraphical Abstract